696 related articles for article (PubMed ID: 11117842)
1. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients.
Stummer W; Novotny A; Stepp H; Goetz C; Bise K; Reulen HJ
J Neurosurg; 2000 Dec; 93(6):1003-13. PubMed ID: 11117842
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.
Aldave G; Tejada S; Pay E; Marigil M; Bejarano B; Idoate MA; Díez-Valle R
Neurosurgery; 2013 Jun; 72(6):915-20; discussion 920-1. PubMed ID: 23685503
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery.
Roessler K; Becherer A; Donat M; Cejna M; Zachenhofer I
Neurol Res; 2012 Apr; 34(3):314-7. PubMed ID: 22449387
[TBL] [Abstract][Full Text] [Related]
4. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring.
Feigl GC; Ritz R; Moraes M; Klein J; Ramina K; Gharabaghi A; Krischek B; Danz S; Bornemann A; Liebsch M; Tatagiba MS
J Neurosurg; 2010 Aug; 113(2):352-7. PubMed ID: 19911888
[TBL] [Abstract][Full Text] [Related]
5. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
[TBL] [Abstract][Full Text] [Related]
6. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G
J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783
[TBL] [Abstract][Full Text] [Related]
7. 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.
Schucht P; Knittel S; Slotboom J; Seidel K; Murek M; Jilch A; Raabe A; Beck J
Acta Neurochir (Wien); 2014 Feb; 156(2):305-12; discussion 312. PubMed ID: 24449075
[TBL] [Abstract][Full Text] [Related]
8. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
[TBL] [Abstract][Full Text] [Related]
9. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.
Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL
Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129
[TBL] [Abstract][Full Text] [Related]
10. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
[TBL] [Abstract][Full Text] [Related]
11. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
Coburger J; Hagel V; Wirtz CR; König R
PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
[TBL] [Abstract][Full Text] [Related]
12. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
13. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
14. Endoscope-assisted fluorescence-guided resection allowing supratotal removal in glioblastoma surgery.
Bettag C; Schregel K; Langer P; Thomas C; Behme D; Stadelmann C; Rohde V; Mielke D
Neurosurg Focus; 2021 Jan; 50(1):E3. PubMed ID: 33386004
[TBL] [Abstract][Full Text] [Related]
15. [Photodynamic diagnosis and fluorescence-guided resection of malignant gliomas: a report of 15 cases].
Cao Y; Zhang MZ; Zhao JZ; Zhang W; Wang L
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):334-8. PubMed ID: 15842947
[TBL] [Abstract][Full Text] [Related]
16. Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping.
Schucht P; Beck J; Abu-Isa J; Andereggen L; Murek M; Seidel K; Stieglitz L; Raabe A
Neurosurgery; 2012 Nov; 71(5):927-35; discussion 935-6. PubMed ID: 22895402
[TBL] [Abstract][Full Text] [Related]
17. Relationship between tumor cell infiltration and 5-aminolevulinic acid fluorescence signals after resection of MR-enhancing lesions and its prognostic significance in glioblastoma.
Kim J-; Jung T-; Jung S; Kim I-; Jang W-; Moon K-; Kim S-; Kim J-; Lee K-
Clin Transl Oncol; 2021 Mar; 23(3):459-467. PubMed ID: 32617871
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative monopolar mapping during 5-ALA-guided resections of glioblastomas adjacent to motor eloquent areas: evaluation of resection rates and neurological outcome.
Schucht P; Seidel K; Beck J; Murek M; Jilch A; Wiest R; Fung C; Raabe A
Neurosurg Focus; 2014 Dec; 37(6):E16. PubMed ID: 25434385
[TBL] [Abstract][Full Text] [Related]
19. [Intraoperative photodynamic diagnosis for spinal ependymoma using 5-aminolevulinic acid: technical note].
Arai T; Tani S; Isoshima A; Nagashima H; Joki T; Takahashi-Fujigasaki J; Abe T
No Shinkei Geka; 2006 Aug; 34(8):811-7. PubMed ID: 16910494
[TBL] [Abstract][Full Text] [Related]
20. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.
Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U;
J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
